Low molecular weight heparin does not increase bleeding and mortality post‐endoscopic variceal band ligation in cirrhotic patients
- 22 February 2018
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 38 (7) , 1253-1262
Abstract
Background & Aims: Anticoagulants are commonly indicated in cirrhotic patients due to high rate of (pro)thrombotic conditions. Low molecular weight heparin (LMWH) is safe in patients with esophageal varices. However, the safety of LMWH is unknown in patients undergoing prophylactic endoscopic variceal ligation (EVL). To define the 4‐week risk of bleeding and death after prophylactic EVL in cirrhotic patients continuously treated with LMWH.Methods: All EVLs performed at a tertiary Italian Center from 2009 to 2016 were retrospectively reviewed. Patients treated with LMWH were classified as on‐LMWH; the remaining as no‐LMWH. Endoscopic characteristics at first and index EVL (that preceding an endoscopy either showing a bleeding episode or the absence of further treatable varices) and clinical events within 4 weeks from the procedures were recorded.Results and Conclusions: Five hundred fifty‐three EVLs were performed in 265 patients (in 215 as a primary prophylaxis): 169 EVLs in 80 on‐LMWH and 384 in 185 no‐LMWH (4.9 ± 1.1 vs 4.8 ± 1.0 bands/session, respectively; P = .796). Six patients bled (2.2%) without between‐groups difference (3.8% on‐LMWH vs 1.6% no‐LMWH, Log‐rank P = .291). Large varices with red marks (100% vs 51.4%, P = .032), number of bands (5.6 ± 0.5 vs 4.6 ± 1.2, P = .004), underlying portal vein thrombosis (66.7% vs 23.6%, P = .033), and creatinine (2.2 ± 2.7 vs 1.0 ± 0.8 mg/dL, P = .001) at index EVL were significantly different between bleeders and non‐bleeders. Six patients died within 4‐week from index EVL, without between‐groups difference (2.5% on‐LMWH vs 2.2% no‐LMWH, Log‐rank P = .863). LMWH does not increase the risk of post‐procedural bleeding and does not affect survival of cirrhotic patients undergoing prophylactic EVL.Keywords
This publication has 38 references indexed in Scilit:
- The Coagulopathy of Chronic Liver DiseaseNew England Journal of Medicine, 2011
- Risk factors for predicting early variceal rebleeding after endoscopic variceal ligationWorld Journal of Gastroenterology, 2011
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- A Prospective Study of Conventional and Expanded Coagulation Indices in Predicting Ulcer Bleeding After Variceal Band LigationClinical Gastroenterology and Hepatology, 2009
- Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed # †Hepatology, 2009
- Multi‐center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in JapanJournal of Gastroenterology and Hepatology, 2009
- Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the WestGastrointestinal Endoscopy, 2008
- Risk factors for severe delayed postpolypectomy bleedingEndoscopy, 2008
- National survey of anticoagulation policy in endoscopyEuropean Journal of Gastroenterology & Hepatology, 2007
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988